@article {154798,
	title = {Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs A Comprehensive Review of Phase 3 Efficacy and Safety},
	journal = {JCR: Journal of Clinical Rheumatology},
	volume = {25-3},
	year = {2019},
	pages = {115-126},
	attachments = {https://scholar.cu.edu.eg/sites/default/files/basselelzorkany/files/original_article_tofacitinib_out_of_jcr.pdf},
	author = {Paul Bird and William Bensen and Bassel El-Zorkany and Jeffrey Kaine and Bernadette Heizel Manapat-Reyes and k Virginia Pascual-Ramos and David Witcombe and Koshika Soma and Richard Zhang and Krishan Thirunavukkarasu}
}
